Paris, France

Patricia Rortais

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Paris, FR (2013)
  • Bourg la Reine, FR (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Patricia Rortais: Innovator in Pharmaceutical Chemistry

Introduction

Patricia Rortais is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. With a total of 3 patents to her name, Rortais has established herself as a key figure in her industry.

Latest Patents

Rortais's latest patents include groundbreaking work on crystalline forms of dimethoxy docetaxel and methods for preparing the same. This invention relates to anhydrides, solvates, and ethanol hetero-solvates and hydrates of dimethoxy docetaxel. Additionally, she has developed taxoid-based compositions, which comprise injectable formulations of these derivatives in the form of an emulsion.

Career Highlights

Throughout her career, Rortais has been associated with Aventis Pharma S.A., where she has played a vital role in advancing pharmaceutical research and development. Her work has not only contributed to the scientific community but has also had a significant impact on patient care through innovative drug therapies.

Collaborations

Rortais has collaborated with notable colleagues such as Pascal Billot and Marielle Dufraigne. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Patricia Rortais is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…